Because DNAJB1 can promote the growth of lung cancer by enhancing EGFR signaling through K48-linked ubiquitination of MIG6, modulation of DNAJB1 might provide a novel therapeutic approach. The gene discussed is EGFR; the disease is lung carcinoma.